ArticleCureus2026
Quality of Life Before and at 6 and 12 Months After Permanent Cardiac Pacemaker Implantation and Recipients' Perspectives and Behaviors: A Cross-Sectional Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Implantation of a permanent cardiac pacemaker (PPM) is critical for managing rhythm disorders and prolonging survival. Beyond clinical outcomes, implantation can affect patients' quality of life (QoL), encompassing physical and mental dimensions. The present study aimed to evaluate QoL among patients undergoing PPM implantation, both before implantation and at 6 and 12 months post-implantation, as well as the associated perspectives and behaviors after 6 and 12 months. Methods In the present study, 112 patients undergoing PPM implantation were enrolled at a public hospital in Athens between 2023 and 2025. Participants were selected by the method of convenience sampling. Data collection was performed using the 36-Item Short Form Health Survey (SF-36). Scores for the Physical Component Summary (PCS) and the Mental Component Summary (MCS) were calculated using QoL scores that range from 0 to 100, with higher scores indicating higher QoL. Statistical analysis was performed using IBM SPSS Statistics for Windows, Version 28 (Released 2021; IBM Corp., Armonk, NY, USA). Statistical significance was set at p < 0.05. Results The PCS presented a mean of 36.2 ± 4.6, and the MCS a mean of 40.9 ± 13.5 before implantation. Post-implantation at 6 and 12 months, the mean PCS score was 34.7 ± 4.9 and 35.3 ± 4.3, respectively, while the mean MCS score was 55.6 ± 8.3 and 59.3 ± 7.7, respectively. Better PCS at 6 and 12 months was associated with adherence to regular follow-up (p = 0.013 and p = 0.027), antiarrhythmic therapy (p = 0.004 and p = 0.041), assistance at home (p = 0.026 and p = 0.012), and being physically active (p = 0.022 and p = 0.004). Better MCS at 6 and 12 months was associated with anxiety about rhythm disorders (p = 0.013 and p = 0.016), participation in social activities (p = 0.001 and p = 0.001), assistance at home (p = 0.001 and p = 0.019), and being physically active (p = 0.001 and p = 0.001). Conclusion Assessing both QoL and patients' perspectives before and after PPM implantation provides valuable insights into the real-world impact of this therapy and informs patient-centered care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.